Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Equity Ratio (2020 - 2024)

Historic Equity Ratio for Burning Rock Biotech (BNR) over the last 5 years, with Q4 2024 value amounting to 0.66.

  • Burning Rock Biotech's Equity Ratio fell 1120.39% to 0.66 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.66, marking a year-over-year decrease of 1120.39%. This contributed to the annual value of 0.66 for FY2024, which is 1120.39% down from last year.
  • Burning Rock Biotech's Equity Ratio amounted to 0.66 in Q4 2024, which was down 1120.39% from 0.74 recorded in Q4 2023.
  • In the past 5 years, Burning Rock Biotech's Equity Ratio registered a high of 0.91 during Q2 2020, and its lowest value of 0.44 during Q4 2021.
  • Over the past 5 years, Burning Rock Biotech's median Equity Ratio value was 0.75 (recorded in 2022), while the average stood at 0.76.
  • In the last 5 years, Burning Rock Biotech's Equity Ratio plummeted by 5169.91% in 2021 and then skyrocketed by 6617.16% in 2022.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Equity Ratio stood at 0.91 in 2020, then crashed by 51.7% to 0.44 in 2021, then surged by 66.17% to 0.73 in 2022, then increased by 1.26% to 0.74 in 2023, then dropped by 11.2% to 0.66 in 2024.
  • Its Equity Ratio was 0.66 in Q4 2024, compared to 0.74 in Q4 2023 and 0.73 in Q4 2022.